BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30381445)

  • 1. Glycoprotein-130 Expression Is Associated with Aggressive Bladder Cancer and Is a Potential Therapeutic Target.
    Martin DT; Shen H; Steinbach-Rankins JM; Zhu X; Johnson KK; Syed J; Saltzman WM; Weiss RM
    Mol Cancer Ther; 2019 Feb; 18(2):413-420. PubMed ID: 30381445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of GP130 and ERK signaling blocks chemoresistant bladder cancer cell growth.
    Li X; He S; Tian Y; Weiss RM; Martin DT
    Cell Signal; 2019 Nov; 63():109381. PubMed ID: 31374291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.
    Rostami N; Nikkhoo A; Khazaei-Poul Y; Farhadi S; Sadat Haeri M; Moghadaszadeh Ardebili S; Aghaei Vanda N; Atyabi F; Namdar A; Baghaei M; Haghnavaz N; Kazemi T; Yousefi M; Ghalamfarsa G; Sabz G; Jadidi-Niaragh F
    J Cell Physiol; 2020 Dec; 235(12):9702-9717. PubMed ID: 32424937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of GP130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis.
    He S; Li G; Schätzlein AG; Humphrey PA; Weiss RM; Uchegbu IF; Martin DT
    Cell Signal; 2021 May; 81():109931. PubMed ID: 33529758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    Luo HB; Li B; Yuan WG; Xu CR
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressing effects of microRNA-612 in bladder cancer cells by targeting malic enzyme 1 expression.
    Liu M; Chen Y; Huang B; Mao S; Cai K; Wang L; Yao X
    Int J Oncol; 2018 Jun; 52(6):1923-1933. PubMed ID: 29620192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of bazedoxifene analogues targeting glycoprotein 130.
    Song D; Yu W; Ren Y; Zhu J; Wan C; Cai G; Guo J; Zhang W; Kong L
    Eur J Med Chem; 2020 Aug; 199():112375. PubMed ID: 32388278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
    Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
    Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression.
    Su H; Tao T; Yang Z; Kang X; Zhang X; Kang D; Wu S; Li C
    Mol Cancer; 2019 Feb; 18(1):27. PubMed ID: 30782157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells.
    Pacini L; De Falco E; Di Bari M; Coccia A; Siciliano C; Ponti D; Pastore AL; Petrozza V; Carbone A; Tata AM; Calogero A
    Cancer Biol Ther; 2014; 15(11):1489-98. PubMed ID: 25482946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.
    Asai A; Miyata Y; Takehara K; Kanda S; Watanabe SI; Greer PA; Sakai H
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):21-31. PubMed ID: 28952025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer.
    Xu S; Grande F; Garofalo A; Neamati N
    Mol Cancer Ther; 2013 Jun; 12(6):937-49. PubMed ID: 23536726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin.
    Buraschi S; Xu SQ; Stefanello M; Moskalev I; Morcavallo A; Genua M; Tanimoto R; Birbe R; Peiper SC; Gomella LG; Belfiore A; Black PC; Iozzo RV; Morrione A
    Oncotarget; 2016 Jun; 7(26):39980-39995. PubMed ID: 27220888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
    Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.